Apollo Endosurgery, Inc. (APEN) News
Filter APEN News Items
APEN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest APEN News From Around the Web
Below are the latest news stories about Apollo Endosurgery Inc that investors may wish to consider to help them evaluate APEN as an investment opportunity.
Apollo Endosurgery up 17% after CFO adds sharesApollo Endosurgery < |
Apollo Endosurgery to Participate in the Cowen Healthcare ConferenceAUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually. |
Investing in Apollo Endosurgery (NASDAQ:APEN) three years ago would have delivered you a 58% gainApollo Endosurgery, Inc. ( NASDAQ:APEN ) shareholders might understandably be very concerned that the share price has... |
Apollo Endosurgery, Inc. 2021 Q4 - Results - Earnings Call PresentationNo summary available. |
Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q4 2021 Results - Earnings Call TranscriptNo summary available. |
Apollo Endosurgery GAAP EPS of -$0.27 misses by $0.09, revenue of $16.2M in-lineApollo Endosurgery press release (APEN): Q4 GAAP EPS of -$0.27 misses by $0.09.Revenue of $16.2M (+26.0% Y/Y) in-line. |
Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue EstimatesApollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -35% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021* Increased adoption across all product lines in both U. and international * Grew fourth quarter 2021 revenue 26%AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. |
SARTORIUS (SARTF) Q4 Earnings and Revenues Surpass EstimatesSARTORIUS (SARTF) delivered earnings and revenue surprises of 1.24% and 1.82%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Earnings Preview: Apollo Endosurgery, Inc. (APEN) Q4 Earnings Expected to DeclineApollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |